These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 20167603)

  • 1. DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1.
    Guo X; Williams JG; Schug TT; Li X
    J Biol Chem; 2010 Apr; 285(17):13223-32. PubMed ID: 20167603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cell survival following DNA damage-mediated premature senescence is regulated by mammalian target of rapamycin (mTOR)-dependent Inhibition of sirtuin 1.
    Back JH; Rezvani HR; Zhu Y; Guyonnet-Duperat V; Athar M; Ratner D; Kim AL
    J Biol Chem; 2011 May; 286(21):19100-8. PubMed ID: 21471201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells.
    Park J; Oh Y; Yoo L; Jung MS; Song WJ; Lee SH; Seo H; Chung KC
    J Biol Chem; 2010 Oct; 285(41):31895-906. PubMed ID: 20696760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MST1 promotes apoptosis through regulating Sirt1-dependent p53 deacetylation.
    Yuan F; Xie Q; Wu J; Bai Y; Mao B; Dong Y; Bi W; Ji G; Tao W; Wang Y; Yuan Z
    J Biol Chem; 2011 Mar; 286(9):6940-5. PubMed ID: 21212262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 downregulates Down syndrome-associated DYRK1A through miR-1246.
    Zhang Y; Liao JM; Zeng SX; Lu H
    EMBO Rep; 2011 Jun; 12(8):811-7. PubMed ID: 21637297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis.
    Laham AJ; Saber-Ayad M; El-Awady R
    Cell Mol Life Sci; 2021 Jan; 78(2):603-619. PubMed ID: 32870330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism.
    Conrad E; Polonio-Vallon T; Meister M; Matt S; Bitomsky N; Herbel C; Liebl M; Greiner V; Kriznik B; Schumacher S; Krieghoff-Henning E; Hofmann TG
    Cell Death Differ; 2016 Jan; 23(1):110-22. PubMed ID: 26113041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation.
    Soppa U; Schumacher J; Florencio Ortiz V; Pasqualon T; Tejedor FJ; Becker W
    Cell Cycle; 2014; 13(13):2084-100. PubMed ID: 24806449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease.
    Barallobre MJ; Perier C; Bové J; Laguna A; Delabar JM; Vila M; Arbonés ML
    Cell Death Dis; 2014 Jun; 5(6):e1289. PubMed ID: 24922073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIPK2 modulates p53 activity towards pro-apoptotic transcription.
    Puca R; Nardinocchi L; Sacchi A; Rechavi G; Givol D; D'Orazi G
    Mol Cancer; 2009 Oct; 8():85. PubMed ID: 19828042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro.
    Adayev T; Chen-Hwang MC; Murakami N; Lee E; Bolton DC; Hwang YW
    Biochemistry; 2007 Jun; 46(25):7614-24. PubMed ID: 17536841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition.
    Soundararajan M; Roos AK; Savitsky P; Filippakopoulos P; Kettenbach AN; Olsen JV; Gerber SA; Eswaran J; Knapp S; Elkins JM
    Structure; 2013 Jun; 21(6):986-96. PubMed ID: 23665168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells.
    Zu Y; Liu L; Lee MY; Xu C; Liang Y; Man RY; Vanhoutte PM; Wang Y
    Circ Res; 2010 Apr; 106(8):1384-93. PubMed ID: 20203304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-specificity kinase DYRK3 phosphorylates p62 at the Thr-269 residue and promotes melanoma progression.
    Lee YH; Yoon AR; Yun CO; Chung KC
    J Biol Chem; 2024 Apr; 300(4):107206. PubMed ID: 38519031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration.
    Branchi I; Bichler Z; Minghetti L; Delabar JM; Malchiodi-Albedi F; Gonzalez MC; Chettouh Z; Nicolini A; Chabert C; Smith DJ; Rubin EM; Migliore-Samour D; Alleva E
    J Neuropathol Exp Neurol; 2004 May; 63(5):429-40. PubMed ID: 15198122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.
    Jung MS; Park JH; Ryu YS; Choi SH; Yoon SH; Kwen MY; Oh JY; Song WJ; Chung SH
    J Biol Chem; 2011 Nov; 286(46):40401-12. PubMed ID: 21965663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct association of Sprouty-related protein with an EVH1 domain (SPRED) 1 or SPRED2 with DYRK1A modifies substrate/kinase interactions.
    Li D; Jackson RA; Yusoff P; Guy GR
    J Biol Chem; 2010 Nov; 285(46):35374-85. PubMed ID: 20736167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyrk kinases regulate phosphorylation of doublecortin, cytoskeletal organization, and neuronal morphology.
    Slepak TI; Salay LD; Lemmon VP; Bixby JL
    Cytoskeleton (Hoboken); 2012 Jul; 69(7):514-27. PubMed ID: 22359282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of dual specificity kinase activity of DYRK1A.
    Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
    FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.